{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:25:37Z","timestamp":1792106737644,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023856","name":"E.J. Whitten Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","award":["MNBCF-17-012"],"award-info":[{"award-number":["MNBCF-17-012"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000951","name":"Cancer Council Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000950","name":"Cancer Council South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008719","name":"Movember Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000927","name":"Prostate Cancer Foundation of Australia","doi-asserted-by":"publisher","award":["PIRA FLECR-0523"],"award-info":[{"award-number":["PIRA FLECR-0523"]}],"id":[{"id":"10.13039\/501100000927","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","award":["61120932"],"award-info":[{"award-number":["61120932"]}],"id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1156570"],"award-info":[{"award-number":["1156570"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1138242"],"award-info":[{"award-number":["1138242"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["44120498"],"award-info":[{"award-number":["44120498"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2011033"],"award-info":[{"award-number":["2011033"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022513","name":"Tasmanian Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","award":["2023_PCRS_0269"],"award-info":[{"award-number":["2023_PCRS_0269"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","award":["2020336"],"award-info":[{"award-number":["2020336"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","award":["2001432"],"award-info":[{"award-number":["2001432"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","award":["MCRF18017"],"award-info":[{"award-number":["MCRF18017"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","award":["MCRF15023"],"award-info":[{"award-number":["MCRF15023"]}],"id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017453","name":"Institute for Prostate Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012737","name":"Department of Health, State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","award":["RG 23-04"],"award-info":[{"award-number":["RG 23-04"]}],"id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["PRF2919"],"award-info":[{"award-number":["PRF2919"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA174777"],"award-info":[{"award-number":["R01CA174777"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA256157"],"award-info":[{"award-number":["R01CA256157"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA234715"],"award-info":[{"award-number":["R01CA234715"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA270539"],"award-info":[{"award-number":["R01CA270539"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["PO1 CA163227"],"award-info":[{"award-number":["PO1 CA163227"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA097186"],"award-info":[{"award-number":["P50CA097186"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.euf.2025.03.017","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T23:44:58Z","timestamp":1744328698000},"page":"790-800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants"],"prefix":"10.1016","volume":"11","author":[{"given":"Mitchell G.","family":"Lawrence","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivakumar","family":"Keerthikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Townley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlee K.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia B.","family":"Cuffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Laven-Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne R.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj K.","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd P.","family":"Knutson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle G.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Crumbaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Joshua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Dehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail P.","family":"Risbridger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne D.","family":"Tilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa E.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renea A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A.","family":"Selth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2025.03.017_b0005","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.euf.2025.03.017_b0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-3-031-11836-4_11","article-title":"AR structural variants and prostate cancer","volume":"1390","author":"Cato","year":"2022","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.euf.2025.03.017_b0015","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1158\/1078-0432.CCR-13-1863","article-title":"Rapid induction of androgen receptor splice variants by androgen deprivation in prostate cancer","volume":"20","author":"Yu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euf.2025.03.017_b0020","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1158\/1078-0432.CCR-19-3023","article-title":"Diverse AR gene rearrangements mediate resistance to androgen receptor inhibitors in metastatic prostate cancer","volume":"26","author":"Li","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euf.2025.03.017_b0025","doi-asserted-by":"crossref","first-page":"T179","DOI":"10.1530\/ERC-16-0422","article-title":"Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence","volume":"23","author":"Coutinho","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.euf.2025.03.017_b0030","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1172\/JCI122819","article-title":"Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer","volume":"129","author":"Sharp","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.euf.2025.03.017_b0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14728222.2018.1439016","article-title":"The potential of AR-V7 as a therapeutic target","volume":"22","author":"Uo","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.euf.2025.03.017_b0040","doi-asserted-by":"crossref","first-page":"16759","DOI":"10.1073\/pnas.1012443107","article-title":"Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor","volume":"107","author":"Watson","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.euf.2025.03.017_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019059","article-title":"Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival","volume":"6","author":"Hornberg","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.euf.2025.03.017_b0050","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1200\/JCO.23.00433","article-title":"Targeting the androgen signaling axis in prostate cancer","volume":"41","author":"Dai","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2025.03.017_b0055","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1038\/s41467-021-25175-5","article-title":"The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology","volume":"12","author":"Risbridger","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.euf.2025.03.017_b0060","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.eururo.2018.06.020","article-title":"Patient-derived models of abiraterone- and enzalutamide-resistant prostate cancer reveal sensitivity to ribosome-directed therapy","volume":"74","author":"Lawrence","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.03.017_b0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/path.5652","article-title":"Androgen receptor enhancer amplification in matched patient-derived xenografts of primary and castrate-resistant prostate cancer","volume":"254","author":"Porter","year":"2021","journal-title":"J Pathol"},{"key":"10.1016\/j.euf.2025.03.017_b0070","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.eururo.2019.05.042","article-title":"Durable response of enzalutamide-resistant prostate cancer to supraphysiological testosterone is associated with a multifaceted growth suppression and impaired DNA damage response transcriptomic program in patient-derived xenografts","volume":"77","author":"Lam","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.03.017_b0075","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201800115","article-title":"Optimized ChIP-seq method facilitates transcription factor profiling in human tumors","volume":"2","author":"Singh","year":"2019","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.euf.2025.03.017_b0080","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jcp.48.9.876","article-title":"A \u201cquickscore\u201d method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas","volume":"48","author":"Detre","year":"1995","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.euf.2025.03.017_b0085","doi-asserted-by":"crossref","first-page":"691","DOI":"10.18632\/oncotarget.975","article-title":"Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors","volume":"4","author":"Gillis","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.euf.2025.03.017_b0090","doi-asserted-by":"crossref","first-page":"13668","DOI":"10.1038\/ncomms13668","article-title":"Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer","volume":"7","author":"Henzler","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.euf.2025.03.017_b0095","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/ng.3419","article-title":"The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis","volume":"47","author":"Pomerantz","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.euf.2025.03.017_b0100","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41588-020-0664-8","article-title":"Prostate cancer reactivates developmental epigenomic programs during metastatic progression","volume":"52","author":"Pomerantz","year":"2020","journal-title":"Nat Genet"},{"key":"10.1016\/j.euf.2025.03.017_b0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.euf.2025.03.017_b0110","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1158\/2159-8290.CD-23-0225","article-title":"The transcriptional and epigenetic landscape of cancer cell lineage plasticity","volume":"13","author":"Davies","year":"2023","journal-title":"Cancer Discov"},{"issue":"9","key":"10.1016\/j.euf.2025.03.017_bib211","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ng.3930","article-title":"TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer","volume":"49","author":"Kron","year":"2017","journal-title":"Nat Genet. Sep"},{"key":"10.1016\/j.euf.2025.03.017_b0115","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1093\/nar\/gkv262","article-title":"Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies","volume":"43","author":"Chan","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.euf.2025.03.017_b0120","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1172\/JCI41824","article-title":"Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant","volume":"120","author":"Sun","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.euf.2025.03.017_b0125","doi-asserted-by":"crossref","first-page":"17492","DOI":"10.1073\/pnas.1308587110","article-title":"TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer","volume":"110","author":"Nyquist","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.euf.2025.03.017_b0130","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/onc.2016.313","article-title":"Systematic and functional characterization of novel androgen receptor variants arising from alternative splicing in the ligand-binding domain","volume":"36","author":"Uo","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.euf.2025.03.017_b0135","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/pcan.2016.17","article-title":"Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting","volume":"19","author":"Antonarakis","year":"2016","journal-title":"Prostate Cancer Prostat Dis"},{"key":"10.1016\/j.euf.2025.03.017_b0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41585-022-00686-y","article-title":"The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications","volume":"20","author":"Kumar","year":"2023","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euf.2025.03.017_b0145","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162396","article-title":"Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC","volume":"132","author":"Sena","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.euf.2025.03.017_b0150","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1073\/pnas.1718811115","article-title":"Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13","volume":"115","author":"Chen","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.euf.2025.03.017_b0155","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.molcel.2018.08.029","article-title":"ZFX mediates non-canonical oncogenic functions of the androgen receptor splice variant 7 in castrate-resistant prostate cancer","volume":"72","author":"Cai","year":"2018","journal-title":"Mol Cell"},{"key":"10.1016\/j.euf.2025.03.017_b0160","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1158\/0008-5472.CAN-15-0381","article-title":"Androgen receptor splice variants dimerize to transactivate target genes","volume":"75","author":"Xu","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.euf.2025.03.017_b0165","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcad045","article-title":"Co-evolution of AR gene copy number and structural complexity in endocrine therapy resistant prostate cancer","volume":"5","author":"Zivanovic","year":"2023","journal-title":"NAR Cancer"},{"key":"10.1016\/j.euf.2025.03.017_b0170","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000510124","article-title":"Molecular origin, expression regulation, and biological function of androgen receptor splicing variant 7 in prostate cancer","volume":"105","author":"Chen","year":"2021","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2025.03.017_b0175","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ccr.2011.09.001","article-title":"Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1","volume":"20","author":"Cai","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.euf.2025.03.017_b0180","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.juro.2016.06.095","article-title":"A whole blood assay for AR-V7 and ARv567es in patients with prostate cancer","volume":"196","author":"Liu","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.03.017_b0185","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1158\/1078-0432.CCR-18-0320","article-title":"Expression of AR-V7 and ARv567es in circulating tumor cells correlates with outcomes to taxane therapy in men with metastatic prostate cancer treated in TAXYNERGY","volume":"25","author":"Tagawa","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euf.2025.03.017_b0190","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s42003-021-02321-9","article-title":"Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage","volume":"4","author":"Gjyrezi","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.euf.2025.03.017_b0195","doi-asserted-by":"crossref","first-page":"10648","DOI":"10.1038\/s41467-024-54847-1","article-title":"AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients","volume":"15","author":"Knutson","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.euf.2025.03.017_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115077","article-title":"Targeting the N-terminal domain of the androgen receptor: the effective approach in therapy of CRPC","volume":"247","author":"Ji","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.euf.2025.03.017_b0205","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1158\/2159-8290.CD-20-0751","article-title":"Targeting the p300\/CBP axis in lethal prostate cancer","volume":"11","author":"Welti","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.euf.2025.03.017_b0210","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1158\/0008-5472.CAN-22-2433","article-title":"LSD1 inhibition disrupts super-enhancer-driven oncogenic transcriptional programs in castration-resistant prostate cancer","volume":"83","author":"Li","year":"2023","journal-title":"Cancer Res"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456925000732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456925000732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:37:06Z","timestamp":1778881026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456925000732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2405456925000732"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2025.03.017","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2025.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}